Announced Wed, 12 Aug · 15:07 IST
Ind-Swift Labs Q1 FY27: Op. EBITDA up 2.85x YoY, PAT up 2.04x YoY
Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionExceptional ItemResults View source PDFExplain this filing
INDSWFTLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.2%1-day move
₹284.68
prior close
₹300.55
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.7-0.9+0.7—+4.2+6.8+10.8+22.9+13.6+16.4————
Up moveDown movePending
AI summary
Ind-Swift Labs posted strong Q1 FY27 results. Operating income grew 21% YoY to Rs 186.08 Cr. Operating EBITDA surged 2.85x to Rs 33.32 Cr with margins expanding 1,258 bps to 17.91%. PAT excluding exceptional items jumped 2.04x to Rs 24.68 Cr. Company is now net debt-free after its API and CRAMS divestment, positioned as a pure-play formulations platform with 85 plus country presence.
Likely market impact
Strong margin expansion and revenue growth signal positive momentum. Company is debt-free with guidance for over 50 percent revenue growth in FY27.